Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells
Condition(s):Myelodysplastic Syndromes (MDS); Chromosmal Aberrations; Karyotype Evolution; Rare Abnormalities; Cytogenetic MonitoringLast Updated:February 21, 2020Completed